Medtronic executive Dr. Stephen Oesterle thinks Google will be a force to be reckoned with in the medical technology space in coming years.
As Medtronic's (NYSE:MDT) resident technology scout and visionary, Dr. Stephen Oesterle's job is to challenge the status quo at the world's largest pure-play medical device company.
Get the complete picture with a MassDevice Plus membership. Registered users can login here.
Need Medtech news in a minute? We Deliver!
MassDevice +3,+5 and +7 newsletters get you caught up on all the mission critical news you need in med tech. Sign up today for our free newsletter.
The special sauce in contract research organization Ora Inc.'s recipe for ophthalmology trials is the eye care practice its founder started 30 years ago.
Animal rights advocacy group PETA holds a tiny stake in several medtech companies, taking frequent advantage of its shareholder rights to push changes in the way device makers experiment on animals.
AliveCor's interim-ish CEO Euan Thomson talks about the data-driven future, why he jumped ship at Accuray and how to navigate the intersection between the tempered medical device world and the wanton nimbleness of Silicon Valley.
Roger Pontz, 1 of the first recipients of Second Sight Medical's Argus II 'bionic eye,' tells MassDevice.com about how it's changed his life.
News and information for the medical device industry and the companies that drive it. Learn the latest about sales, jobs, legislation and other areas of the medtech industry.